BIOMAT Database Logo BIOMAT Database Logo

Low-dose aminoglutethimide and aromatase inhibition. 1985

M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith

UI MeSH Term Description Entries
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000616 Aminoglutethimide An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER. Cytadren,Orimeten
D047072 Aromatase Inhibitors Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones. Aromatase Inhibitor,Inhibitor, Aromatase,Inhibitors, Aromatase

Related Publications

M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
Analogues of aminoglutethimide: selective inhibition of aromatase.
February 1985, Journal of medicinal chemistry,
M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide.
July 1979, Endocrinology,
M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide.
January 1987, Oncology,
M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
Selective aromatase inhibition by pyridoglutethimide, an analogue of aminoglutethimide.
May 1990, Acta endocrinologica,
M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer.
September 1995, Breast cancer research and treatment,
M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
In vitro inhibition of aromatase by the enantiomers of aminoglutethimide and analogs.
January 1994, Chirality,
M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
Inhibition of aromatase activity in the rat by aminoglutethimide and related compounds.
March 1987, Journal of steroid biochemistry,
M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibition.
October 1989, Journal of steroid biochemistry,
M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
First generation aromatase inhibitors--aminoglutethimide and testololactone.
January 1994, Breast cancer research and treatment,
M Dowsett, and S L Jeffcoate, and S Santner, and R J Santen, and R Stuart-Harris, and I E Smith
Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
June 1994, British journal of cancer,
Copied contents to your clipboard!